Azacitidine Injection · 2,093 days since initial FDA posting
Brand: AZACITIDINE
FDA lists Azacitidine Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Azacitidine Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azacitidine Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)
- Package NDC
- 63323-771-39
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 18, 2020
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
4 & 7 month expiry available on request. Check wholesalers for inventory.
Nearby, Other Azacitidine Shortage Records
Azacitidine Injection
Meitheal Pharmaceuticals, Inc.
Injection
Azacitidine Injection
Eugia US LLC
Injection
Azacitidine Injection
Bristol Myers Squibb Co.
Injection
Azacitidine Injection
Accord Healthcare Inc.
Injection
Azacitidine Injection
Dr. Reddy's Laboratories, Inc.
Injection
Azacitidine Injection
Teva Pharmaceuticals USA, Inc.
Injection
FDA reason on file: 4 & 7 month expiry available on request. General shortage guidance lives on the tracker hub.